.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Hydroflumethiazide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for hydroflumethiazide?

Hydroflumethiazide is the generic ingredient in seven branded drugs marketed by Watson Labs, Shire Llc, Par Pharm, Wyeth Ayerst, Ivax Pharms, Shire, and Usl Pharma, and is included in eleven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for hydroflumethiazide.

Summary for Generic Name: hydroflumethiazide

Tradenames:7
Patents:1
Applicants:7
NDAs:11
Drug Master File Entries: see list2
Bulk Api Vendors: see list39
Patent Applications: see list4,409
Therapeutic Class:Cardiovascular Agents
Drug Prices:see low prices
DailyMed Link:hydroflumethiazide at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
RESERPINE AND HYDROFLUMETHIAZIDE
hydroflumethiazide; reserpine
TABLET;ORAL088907-001Sep 20, 1985DISCNNoNo► Subscribe► Subscribe
Shire Llc
SALURON
hydroflumethiazide
TABLET;ORAL011949-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Watson Labs
HYDROFLUMETHIAZIDE
hydroflumethiazide
TABLET;ORAL088031-001Apr 6, 1983DISCNNoNo► Subscribe► Subscribe
Wyeth Ayerst
DIUCARDIN
hydroflumethiazide
TABLET;ORAL083383-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
HYDROFLUMETHIAZIDE AND RESERPINE
hydroflumethiazide; reserpine
TABLET;ORAL088127-001Mar 22, 1983DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc